Journey Medical dermatology revenue plus Emrosi near-term sales and a rare pediatric disease PRV from Zycubo approval. See more on FBIO.
ThreatsDay Bulletin tracks active exploits, phishing waves, AI risks, major flaws, and cybercrime crackdowns shaping this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results